SHARE: +/-: 0.00 SEK / Bid: 14.75 SEK / Ask: 15.50 SEK / Price: 15.50 SEK / High: 15.80 SEK / Low: 14.80 SEK / Quantity: 3 717 / Turnover: 56 878 SEK / 2019-12-13 16:28 (CET)
 

Business Development

Spago Nanomedical focuses on the development of novel nanomedical tumor selective products for cancer diagnostics and therapy.

We welcome a dialogue with potential partners regarding cooperation and out-licensing of the company’s projects and technologies.

For more information regarding business development, please contact CEO Mats Hansen at mats.hansen@spagonanomedical.se